IMAC
Undervalued by 63.8% based on the discounted cash flow analysis.
Market cap | $33.08 Million |
---|---|
Enterprise Value | $32.58 Million |
Dividend Yield | $0 (0%) |
Earnings per Share | $-5.76 |
Beta | -0.89 |
Outstanding Shares | 1,569,627 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -0.01 |
---|---|
PEG | 0 |
Price to Sales | - |
Price to Book Ratio | -0.2 |
Enterprise Value to Revenue | 452.16 |
Enterprise Value to EBIT | -5.58 |
Enterprise Value to Net Income | -4 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data
IMAC was created in March 2015 to expand on the footprint of the original IMAC Regeneration Center, which opened in Kentucky in August 2000. IMAC Regeneration Centers combine life-science advancements with traditional medical care for mo...